Skip to Main Content

Paper Details

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Nature
7
2023
Author NameAffiliation
Adam SharpThe Institute of Cancer Research
Adam SharpThe Royal Marsden NHS Foundation Trust
Wei YuanThe Institute of Cancer Research
Suzanne CarreiraThe Institute of Cancer Research
Alec PaschalisThe Institute of Cancer Research
Alec PaschalisThe Royal Marsden NHS Foundation Trust
Nina TunariuThe Royal Marsden NHS Foundation Trust
Penny FlohrThe Institute of Cancer Research
Johann S de BonoThe Institute of Cancer Research
Johann S de BonoThe Royal Marsden NHS Foundation Trust
  • 1 - 10

Datasets

Release 1.2